![]() |
市場調查報告書
商品編碼
1383348
到 2030 年膠囊填充機的全球市場預測:按產品類型、容量類型、膠囊尺寸、劑量類型、材料、最終用戶和地區進行的全球分析Capsule Filling Machines Market Forecasts to 2030 - Global Analysis By Product Type, Capacity Type, Capsule Size, Dosage Type, Material, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球膠囊填充機市場規模為 19.2 億美元,預計預測期內年複合成長率為 8.7%,到 2030 年將達到 34.4 億美元。
膠囊製造過程需要使用各種膠囊填充機來填充含有活性成分、其混合物和賦形劑組合的各種粉末和製劑,醫生用這些機器來治療各種疾病,向患者推薦這些膠囊。
根據美國商務部國際貿易管理局(ITA)的數據,美國是全球最大的醫療設備市場。 2017年美國整體估值為1,560億美元,預計2023年將達2,080億美元。
人口高齡化、醫療成本上升和新藥開發等因素推動了製藥業的強勁成長,推動了對大容量膠囊填充機的需求。此外,這些設備對於丸劑、顆粒劑、粉劑等各種劑型的生產至關重要,幫助製藥公司有效滿足消費者的需求。
儘管現代膠囊填充機具有多功能性,但有時可能難以適應新穎和不尋常的配方。有些配方可能需要專門的設備,特別是如果它們具有特殊的性質或輸送機制。此外,對製造商來說,改造現有機械以適應新產品開發可能很困難。
隨著學名藥產業的持續成長,蘊藏著巨大的機會。隨著名牌藥物的專利到期,對有效且負擔得起的製造流程的需求增加。此外,膠囊填充機是學名藥生產的重要組成部分,使我們能夠快速、經濟地生產各種學名藥膠囊。
由於市場競爭激烈,製造商可能會捲入價格戰。當價格主導的競爭降低報酬率時,投資於促進創新和產品差異化的研發計劃就變得困難。製造商還需要在技術、客戶服務和品牌方面跳出固有思維,才能在擁擠的市場中脫穎而出。
膠囊填充機市場受到 COVID-19大流行的多方面影響。疫情爆發初期,全球供應鏈和製造業務中斷導致設備生產和分銷延遲。此外,病毒傳播的不確定性增加了對自動化和衛生膠囊填充機的需求。影響市場成長的負面因素包括財務困難、製藥公司資本投資減少以及對非必要商業活動的法規。此外,對醫療保健的關注進一步凸顯了複雜而有效的膠囊填充機對於製藥和補充劑製造的重要性,而製藥和營養補充食品仍然有能力抵消市場下滑的影響。仍然是服務於醫療保健的重要行業。
預計自動化部門的市場佔有率最高。全自動膠囊充填機因其高速、高精度、高效率而成為營養補充和食品業的首選。這些設備可以準確快速地填充膠囊,最大限度地減少人為干涉的需要並減少出錯的可能性。此外,它在生產率、品管和成本效益方面具有優勢,適合大規模生產。為了滿足對膠囊不斷成長的需求,同時保持穩定的產品品質並嚴格遵守法規標準,製藥和營養補充食品經常採用自動化機械。
膠囊填充機市場預計將以生物公司領域最高的年複合成長率成長。開發和製造疫苗、生物製藥和其他生技藥品的生物技術相關企業需要更先進的膠囊填充機來封裝精緻而有價值的材料。隨著基因工程和生物技術的進步推動生物製藥行業的成長,為滿足生物產品獨特需求而設計的專用膠囊填充機的需求預計將激增。此外,這些設備可確保生技藥品的準確和無菌封裝,使其成為相關企業生產過程中不可或缺的一部分。
包括美國和加拿大在內的北美地區預計將佔據膠囊填充機市場的最大佔有率。這一優勢得益於該地區完善的醫療保健和營養補充食品、嚴格的法規、高額的醫療保健支出以及對創新和產品品質的重視。北美的富裕程度允許採用膠囊填充機等尖端製造技術。此外,強大的製藥管道和對研發的持續關注正在推動對這些設備的需求。
膠囊填充機市場預計將在亞太地區擁有最高的年複合成長率。多用戶住宅和公共基礎設施的發展、製藥和營養補充食品的成長、都市化的加快以及中階的壯大是支持這一強勁成長的一些因素。隨著可支配所得的增加,亞太地區家庭對健康和保健的日益關注,推動了對藥品、營養補充食品最終膠囊填充機的需求。此外,該地區不斷提高的安全和法規標準也推動了先進膠囊製造技術的採用。
According to Stratistics MRC, the Global Capsule Filling Machines Market is accounted for $1.92 billion in 2023 and is expected to reach $3.44 billion by 2030 growing at a CAGR of 8.7% during the forecast period. The process of making capsules entails filling various powders or formulations containing active ingredients and their mixtures, as well as combinations of excipients, using a variety of capsule-filling machines, doctors recommend these capsules to their patients in order to treat a range of illnesses.
According to the International Trade Administration (ITA), the US Department of Commerce is the world's largest market for medical devices. Its overall valuation was US$ 156 billion in 2017, which is expected to reach US$ 208 billion by 2023.
The need for high-capacity capsule filling machines stems from the pharmaceutical industry's strong growth, which is fueled by factors like aging populations, rising healthcare costs, and the development of new medications. Moreover, these devices are essential to the production of different drug formulations, such as pellets, granules, and powders, which help pharmaceutical companies effectively, meet consumer demand.
Despite their versatility, contemporary capsule filling machines may have issues handling novel and unusual drug formulations. Some formulations may require specialized equipment, especially if they have special characteristics or delivery mechanisms. Additionally, this can make it challenging for manufacturers to modify their current machinery to accommodate the development of new products.
There is a big opportunity due to the generic pharmaceutical industry's continued growth. Demand for effective and affordable manufacturing processes is rising as more patents for name-brand medications expire. Furthermore, the ability of manufacturers to swiftly and affordably produce a large variety of generic capsules is made possible by capsule filling machines, which can be crucial in the production of generic drugs.
Manufacturers may engage in price wars as a result of the fierce market competition. It can be difficult for businesses to invest in R&D projects that could spur innovation and product differentiation when price-driven competition erodes profit margins. Moreover, manufacturers need to think outside the box when it comes to technology, customer service, and branding in order to stand out in a crowded market.
The market for capsule filling machines was impacted in a number of ways by the COVID-19 pandemic. Early in the pandemic, delays in equipment production and distribution were caused by disruptions in global supply chains and manufacturing operations. There was also a rise in demand for automated and sanitary capsule filling machines due to the uncertainty surrounding the virus's spread. Negative factors affecting market growth included financial difficulties, pharmaceutical companies cutting back on capital expenditures, and regulations on non-essential business operations. Additionally, the focus on healthcare further highlighted the significance of sophisticated and effective capsule filling machines for medicine and supplement production, but the pharmaceutical and nutraceutical sectors continued to be vital industries that helped offset the market's fall.
It is projected that the automatic segment will have the largest market share. For their high speed, accuracy, and efficiency, automatic capsule filling machines are preferred in the nutraceutical and pharmaceutical industries. These devices can fill capsules precisely and swiftly, minimizing the need for human intervention and lowering the possibility of mistakes. Moreover, they are advantageous in terms of productivity, quality control, and cost-effectiveness and are appropriate for large-scale production. For the purpose of satisfying the increasing demand for capsules while maintaining consistent product quality and strict adherence to regulatory standards, pharmaceutical and nutraceutical manufacturers frequently favor automatic machines.
The market for capsule filling machines is expected to grow at the highest CAGR in the biological company segment. Biological companies that develop and produce vaccines, biopharmaceuticals, and other biologics need more sophisticated capsule filling machines to encapsulate sensitive and valuable materials. With advances in genetic engineering and biotechnology propelling the biopharmaceutical industry's growth, demand for specialized capsule filling machines designed to meet the specific needs of biological products is anticipated to soar. Additionally, these devices are a vital part of biological companies' production processes because they guarantee the accurate and sterile encapsulation of biologics.
It is projected that in the capsule filling machine market, the North American region, which includes the United States and Canada, will hold the largest share. This dominance is ascribed to the region's well-established healthcare and nutraceutical industries, strict regulations, high spending on healthcare, and a strong emphasis on innovation and product quality. The wealth of North America makes it possible for cutting-edge manufacturing technologies, such as capsule filling machines, to be adopted. Furthermore, a robust pharmaceutical pipeline and an ongoing focus on research and development fuel demand for these devices.
In the market for capsule filling machines, the Asia-Pacific region is projected to have the highest CAGR. The development of multi-story housing and public infrastructure, the growth of the pharmaceutical and nutraceutical industries, rising urbanization, and the middle class are some of the factors driving this robust growth. The demand for pharmaceuticals, dietary supplements, and, eventually, capsule filling machines is driven by the growing emphasis on health and wellness among families in the Asia-Pacific region as disposable incomes rise. Additionally, the adoption of advanced technologies for capsule production is being encouraged by the region's heightened safety and regulatory standards.
Some of the key players in Capsule Filling Machines market include: Kambert Machinery Co. Pvt. Ltd., Hanlin Hangyu Industrial Co., Ltd., Capsugel, Inc, Dott Bonapace & C Srl, ACIC Pharmaceutical Machinery, Harro Hofliger Verpackungsmaschinen GmbH, Torpac Inc. , Jornen Machinery Co., Ltd., Qualicaps Co., Ltd., Robert Bosch GmbH, IMA Industria Macchine Automatiche SpA, Zhejiang Fuchang Machinery, N.K Industries , SaintyCo International Group, Shanghai Jiuwu Pharmtech Machinery Co. Ltd., Titan Pharmaceutical Machinery, ACG Pam Pharma Technologies Private Limited , Romaco Group, M2G S.r.l, Schaefer Technologies Inc and Adinath International.
In July 2023, Qualicaps acquired by Roquette. Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, announced today an agreement to acquire Qualicaps and reinforce its position as a major supplier to the pharmaceutical industry. The combination of the two businesses will contribute to Roquette's strategic growth plan and will create new opportunities for Roquette and Qualicaps' customers and employees.
In April 2022, Harro Hofliger will take over the business operations of Widmann Maschinen GmbH & Co. KG in Schlierbach and thus invest in the growth market of pharmaceuticals and medical technology. Widmann Maschinen, founded in Esslingen in 1946, develops, builds and maintains series and special machines that are used for packaging food and cosmetics, in the automotive industry and medical technology. The family business specializes in manufacturing of film processing and bag filling systems as well as the ultrasonic welding of film materials.
In February 2022, Titan International, Inc. and Kubota Tractor Corporation (KTC) / Kubota Canada Limited (KCL) have entered into an exclusivity agreement on select sizes of Titan's new Trac Loader II tires for compact and utility tractor models used in residential, commercial, agricultural, and light construction applications. This innovative tire, branded with Titan and Kubota both displayed on the sidewall of the tire, will bring new value to Titan and Kubota customers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.